Company Profile

Diagnostic Biochips Inc
Profile last edited on: 4/12/21      CAGE: 6W3E6      UEI: PF2EA6V5G9E3

Business Identifier: Chemical sensing technology for designing medical devices and implants
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

802 Cromwell Park Drive Suite N
Glen Burnie, MD 21061
   (410) 205-2443
Location: Single
Congr. District: 03
County: Howard

Public Profile

Diagnostic Biochips, Inc is anchored in a biosensor platform technology that - by enabling direct and continuous monitoring of critical drugs and biomarkers - may redefine measurement in medicine. The Company has developed a proprietary sensor ‘functionalization’ process and a suite of biosensors set to transform the medical monitoring process. The firm's paradigm-shifting sensors are a cost-effective method for the direct and continuous monitoring of medically important chemicals: a proprietary fast-response chemical sensing technology for use inside the body. Designed to make medical devices and implants "smart", the firm's capabilities provide information on biological activity: data that can be used in various applications: basic science research, neuromodulation, continuous diagnostics, and pharmacodynamic analysis. The medical practitioner orders blood and urine tests, biopsies and other tissue samples. These procedures yield biochemical concentrations at the specific with almost no other information available re. how concentrations vary with time. In the case of stroke or heart attack, for example, it has been shown that the presence of certain biomarkers indicates a high probability of onset.. However, with no practical means to monitor an at-risk patient for the sudden appearance of these indicators is less than useful. Initially focusing primarily on applying its technology in the area of pre-clinical drug development, Diagnostic Biochips sells its first product -- the Neuro Mapping Microsensor (NMM) -- through distributor Cambridge NeuroTech.This silicon probe product is used by neuroscientists to study how the brain processes information. Drug discovery groups at pharmaceutical companies and contract research organizations are using the NMM sensors to study the efficacy of novel drug candidates for a variety of neurological diseas

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Robert S Collins -- Co-Founder, President and CEO

  Brian Glenn Jamieson -- Co-Founder, President and CTO

  Emma (Tall) Bigelow -- VP R&D